These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2576810)

  • 1. Some central effects of repeated treatment with fluvoxamine.
    Maj J; Dereń A; Moryl E
    Pol J Pharmacol Pharm; 1989; 41(4):305-12. PubMed ID: 2576810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some central effects of opipramol given repeatedly.
    Skuza G; Rogóz Z; Sowińska H
    Pol J Pharmacol Pharm; 1990; 42(5):425-31. PubMed ID: 2098752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects following repeated treatment with antidepressant drugs.
    Maj J
    Pol J Pharmacol Pharm; 1984; 36(2-3):87-99. PubMed ID: 6089162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of 5HT reuptake inhibitors and ethanol in tests of exploration and anxiety.
    Durcan MJ; Lister RG; Eckardt MJ; Linnoila M
    Adv Alcohol Subst Abuse; 1988; 7(3-4):113-7. PubMed ID: 3146920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril lacks the antidepressant-like activity in animal models.
    Baran L; Siwanowicz J; Nowak G; Przegaliński E
    Pol J Pharmacol Pharm; 1991; 43(4):265-70. PubMed ID: 1667333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central action of carbamazepine as a potential antidepressant drug.
    Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant activities of WEB 1881, a new nootropic agent.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Nowak G
    Pol J Pharmacol Pharm; 1989; 41(5):439-52. PubMed ID: 2561889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of repeated treatment with antidepressant drugs on the 24 hour behavior in the light-dark synchronized mice.
    Górka Z; Maj J
    Pol J Pharmacol Pharm; 1986; 38(5-6):493-9. PubMed ID: 3575167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
    Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
    Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some central effects of brofaromine given repeatedly are phase-dependent.
    Górka Z; Zajaczkowski W
    Pol J Pharmacol Pharm; 1990; 42(4):313-20. PubMed ID: 2097592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologically distinctive behaviors other than burying marbles during the marble burying test in mice.
    Hayashi E; Kuratani K; Kinoshita M; Hara H
    Pharmacology; 2010; 86(5-6):293-6. PubMed ID: 21042039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of Ro 19-6327 given acutely and repeatedly.
    Skuza G; Rogóz Z
    Pol J Pharmacol Pharm; 1991; 43(6):437-47. PubMed ID: 1668212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central effects of repeated treatment with bupropion.
    Klimek V; Nowak G; Czyrak A
    Pol J Pharmacol Pharm; 1985; 37(3):243-52. PubMed ID: 3934652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
    Dziedzicka-Wasylewska M; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
    Rogoz Z; Wrobel A; Dlaboga D; Maj J; Dziedzicka-Wasylewska M
    J Physiol Pharmacol; 2002 Mar; 53(1):105-16. PubMed ID: 11939713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
    Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
    Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
    Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
    Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.